Final NICE guidance recommends high-sensitive troponin tests to help evaluate heart attacks more quickly


The National Institute for Health and Care Excellence (NICE) has recommended Abbott’s Architect Stat High Sensitive Troponin-I (hsTnl) test, among others, to help doctors quickly rule out heart attacks in NHS emergency departments in England and Wales. Using high sensitive troponin tests, doctors may reduce the time for evaluating heart attacks by several hours compared to standard troponin tests, which can take up to 12 hours for results.

An Abbott press release reports that these tests can also identify patients at higher risk for another heart attack 30 days later, allowing doctors to provide the most appropriate treatment to these patients to help prevent another cardiac event.

“Abbott’s highly sensitive troponin test can help doctors precisely measure very low levels of this protein, allowing them to evaluate whether or not patients are having a heart attack within two to four hours after admission to the emergency department,” said Agim Beshiri, senior medical director, Medical Affairs, Diagnostics, Abbott. “This faster evaluation could help decrease time to diagnosis or prevent additional unnecessary procedures to reach a diagnosis.”